Yet, recently we underlined that circulating DCs decline in CAD, irrespective of the subset marker (BDCA-1 or CD11c for mDCs, BDCA-2 or CD123 for pDCs) that was used for enumeration [30]. Here, CLEC4C is linked to coronary artery disorder.